Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-04-14 @ 9:35 PM
Study NCT ID:
NCT04909034
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2021-05-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Sponsor:
Microbio Co Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | NSCLC Stage IIIB~IV | View |